BETA-TALASSEMIA INTERMEDIA E MINOR (ETÀ PEDIATRICA)
Cure palliative
Italiano
Cure palliative
/assets/ct/fa815d8e9f/images/syn_placeholder_sqr.png

Beta-talassemia intermedia e minor (età pediatrica)

Cure palliative

Chelazione del ferro

Iron out for nontransfused thalassemia. (apre una nuova finestra)

Marks PW.

Fonte‎: Blood 2012;120(5):928-9.

Iron overload in β-thalassemia intermedia: an emerging concern. (apre una nuova finestra)

Musallam KM, Cappellini MD, Taher AT.

Fonte‎: Curr Opin Hematol 2013;20(3):187-92.

Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia. (apre una nuova finestra)

Taher AT, Temraz S, Cappellini MD.

Fonte‎: Expert Rev Hematol 2013;6(5):495-509.

Integratori alimentari e altre terapie di sostegno

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (apre una nuova finestra)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Fonte‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Therapeutic roles of curcumin: lessons learned from clinical trials. (apre una nuova finestra)

Gupta SC, Patchva S, Aggarwal BB.

Fonte‎: AAPS J 2013;15(1):195-218.

Determining and surveying the role of carnitine and folic acid to decrease fatigue in β-thalassemia minor subjects. (apre una nuova finestra)

Tabei SM, Mazloom M, Shahriari M, Zareifar S, Azimi A, Hadaegh A, Karimi M.

Fonte‎: Pediatr Hematol Oncol 2013;30(8):742-7.